Severe mixed rejection after liver transplantation caused by preoperative use of programmed death-1 inhibitor: a case report

doi:10.3877/cma.j.issn.1674-3903.2022.02.009

Abstract

Key words: Liver transplantation, Programmed death-1, Liver cancer, Rejection

Hanwen Yang, Qiang Wang, Ke Cheng, Yingzi Ming, Yujun Zhao. Severe mixed rejection after liver transplantation caused by preoperative use of programmed death-1 inhibitor: a case report[J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(02): 105-107.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2022.02.009

https://zhyzzz.cma-cmc.com.cn/EN/Y2022/V16/I02/105

Figures/Tables 1

References 12

1	Munker S, De Toni EN. Use of checkpoint inhibitors in liver transplant recipients[J]. United European Gastroenterol J, 2018, 6(7): 970-973.
2	Kumar V, Shinagare AB, Rennke HG, et al. The safety and efficacy of checkpoint inhibitors in transplant recipients: a case series and systematic review of literature[J]. Oncologist, 2020, 25(6): 505-514.
3	宾阳阳，李杰群，李强，等. PD-1单克隆抗体治疗实体器官移植术后恶性肿瘤的系统评价[J]. 器官移植，2020, 11(3): 384-390.
4	崔春晓，杨柳晓，王颖，等. 肝癌患者肝移植术前使用PD-1抑制剂对移植后排斥反应的影响[J]. 中国临床医学，2020, 27(3): 444-447.
5	刘召波，武聚山，林栋栋，等. PD-1抑制剂用于肝癌肝移植术前治疗的安全性探讨[J]. 器官移植，2021, 12(4): 445-449.
6	Nordness MF, Hamel S, Godfrey CM, et al. Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: are checkpoint inhibitors safe for the pretransplant patient？[J]. Am J Transplant, 2020, 20(3): 879-883.
7	Desai J, Deva S, Lee JS, et al. Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors[J]. J Immunother Cancer, 2020, 8(1): e000453.
8	李照，朱继业. 免疫治疗时代下的肝癌肝移植[J]. 临床肝胆病杂志，2021(2): 249-252.
9	DeLeon TT, Salomao MA, Aqel BA, et al. Pilotevaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience[J]. J Gastrointest Oncol, 2018, 9(6)：1054-1062.
10	Hogen R, DiNorcia J, Dhanireddy K. Antibody-mediated rejection: what is the clinical relevance？[J]. Curr Opin Organ Transplantation, 2017, 22(2): 97-104.
11	Lee M. Antibody-mediated rejection after liver transplant[J]. Gastroenterol Clin North Am, 2017, 46(2): 297-309.
12	Wozniak LJ, Naini BV, Hickey MJ, et al. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: caseseries and review of the literature[J]. Pediatr Transplant, 2017, 21(1): e12791.

[1]	Kunhe Li, Mengjia Kou, Liting Kuang. Risk factors and prediction model of reintubation after liver transplantation [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(05): 366-371.
[2]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[3]	Branch of Organ Transplant of Chinese Medical Association, Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Shanghai Pharmaceutical Profession Association. Expert Consensus on the Use of Mycophenolic Acid in Chinese Liver and Kidney Transplant Recipients (2023 edition) [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 257-272.
[4]	Wenqing Lu, Xinyi Chen, Xuefei Ren. Investigation on the quality of life after liver transplantation in children with genetic metabolic diseases [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 287-292.
[5]	Tieyan Fan, Jun Li, Hong Chen. Diagnosis and treatment experience of new onset viral hepatitis E after liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 293-296.
[6]	Shuo Chen, Feng Chen, Fei Cheng, Jie Xiang. Pancreas infarction after liver transplantation for glycogen storage disease type Ⅰ complicated with pancreatitis: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 300-302.
[7]	Penghao Tang, Wu Zhang. Progress in mechanism research about intestinal microecology with perioperative complications of liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 303-307.
[8]	Qing Yan, Ying Liu, Feiwen Deng, Huanwei Chen. Effect of microvascular invasion on survival and prognosis of liver transplantation recipients with liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 624-629.
[9]	Mei Liao, Hongjun Zhang, Jieyang Jin, Yan Lyu, Jie Ren. Diagnostic value of bedside contrast-enhanced ultrasound for early hepatic artery thrombosis after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 630-634.
[10]	Binglin Li, Shaocheng Lyu, Fei Pan, Tao Jiang, Hua Fan, Jiantao Kou, Qiang He, Ren Lang. Correlation analysis between pathogenic bacteria of donor liver perfusion fluid and early infection after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 656-660.
[11]	Lei Lyu, Xiao Feng, Kaiming He, Kaining Zeng, Qing Yang, Haijin Lyu, Huimin Yi, Shuhong Yi, Yang Yang, Binsheng Fu. Value of revised King's score in evaluation of live transplantation timing for children with acute liver failure due to Wilson's disease and literature review [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 661-668.
[12]	Haitao Zhang, Zhe Jia, Chao Ma, Qikun Zhang, Jushan Wu, Qingliang Guo, Daobing Zeng, Guangming Li, Menglong Wang. Comparison of clinical efficacy of liver resection and radiofrequency ablation for peripheral single small hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 523-527.
[13]	Cuiping Li, Xiaoyan Chen, Shiyu Qian, Huizhu Lin, Caihui Zeng, Li Yang, Jianxi Lu. Effects of different anticoagulant preservation solutions on the proliferation and killing effects of NK cells cultured in umbilical cord blood [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 572-576.
[14]	Bing Han, Jinyang Gu. Research and application prospect of deep learning neural network in diagnosis and treatments for liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 480-485.
[15]	Menglong Wang. Significance of biological characteristics in liver transplantation for HCC [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 490-494.

Please choose a citation manager

Content to export

Severe mixed rejection after liver transplantation caused by preoperative use of programmed death-1 inhibitor: a case report

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 1

References 12

Related Articles 15

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Severe mixed rejection after liver transplantation caused by preoperative use of programmed death-1 inhibitor: a case report

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 1

References 12

Related Articles 15

Recommended Articles

Metrics

Comments